We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Life Science Reit Plc | LSE:LABS | London | Ordinary Share | GB00BP5X4Q29 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.10 | 0.26% | 38.50 | 38.50 | 38.90 | 39.00 | 38.30 | 39.00 | 246,608 | 14:38:53 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Real Estate Investment Trust | 15.71M | -27.61M | -0.0789 | -4.89 | 135.1M |
From Nov 2023 to May 2024
TIDMLABS
RNS Number : 1531Z
Life Science REIT PLC
09 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BP5X4Q29
Issuer Name
LIFE SCIENCE REIT PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Hazelview Investments Inc.
City of registered office (if applicable)
Toronto
Country of registered office (if applicable)
Canada
4. Details of the shareholder
Hot Features
Premium
Name City of registered office Country of registered office
Hazelview Securities (US) LLC Toronto Canada
=========================== ==============================
Hazelview Securities Inc. Toronto Canada
=========================== ==============================
5. Date on which the threshold was crossed or reached
20-Dec-2023
6. Date on which Issuer notified
09-Jan-2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 4.940000 0.000000 4.940000 17300631
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 5.980000 0.000000 5.980000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BP5X4Q29 17300631 4.940000
====================== ====================== ====================== ======================
Sub Total 8.A 17300631 4.940000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling Name of controlled undertaking % of voting rights % of voting rights Total of both if it
person if it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable equals or is threshold
threshold higher than the
notifiable
threshold
Hazelview Universal-Investment-Luxembourg
Investments Inc. S.A. (Client of Hazelview
(Chain 1) Securities Inc.) 3.810000 0.000000 3.810000%
=================================== ================== ================== ===================
Hazelview Hazelview Securities (US) LLC
Investments Inc. (Subsidiary 2)
(Chain 2)
=================================== ================== ================== ===================
Hazelview Hazelview Securities Inc.
Investments Inc. (Subsidiary 1)
(Chain 1)
=================================== ================== ================== ===================
10. In case of proxy voting
Name of the proxy holder
Hazelview Securities Inc. and Hazelview Securities (US) LLC on behalf of its client accounts.
The number and % of voting rights held
17300631, 4.94%
The date until which the voting rights will be held
Until the securities are sold.
11. Additional Information
12. Date of Completion
09-Jan-2024
13. Place Of Completion
Toronto, Ontario, Canada
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUPUQPGUPCGMB
(END) Dow Jones Newswires
January 09, 2024 12:29 ET (17:29 GMT)
1 Year Life Science Reit Chart |
1 Month Life Science Reit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
